Kobayashi Pharmaceutical Co., Ltd. (4967)

Name: Kobayashi Pharmaceutical Co., Ltd. (4967) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Consumer Defensive · Wall Street (EE. UU.) · Última actualización: 2026-10-02

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.

Cifras clave

Capitalización bursátil: JPY 528 billion
Ingresos (ejercicio cerrado en 2025-12-31): JPY 165.7B
Beneficio neto: JPY 3.7B
Margen bruto: 51.1%
Margen neto: 2.2%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ingresos totales	JPY 165.7B	JPY 165.6B	JPY 173.5B	JPY 166.3B	—
Beneficio bruto	JPY 84.7B	JPY 87.6B	JPY 96.4B	JPY 92.3B	—
Ingresos operativos (EBIT)	JPY 14.9B	JPY 24.9B	JPY 25.8B	JPY 26.7B	—
Ingresos netos	JPY 3.7B	JPY 10.1B	JPY 20.3B	JPY 20.0B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 4967. /companies/us/4967

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.